Adlego Biomedical

Adlego Biomedical is a Swedish contract research organization (CRO) specializing in preclinical drug development services. The company provides a comprehensive suite of in vitro and in vivo pharmacology, toxicology, and pharmacokinetic studies to support biotech and pharmaceutical clients. Adlego is particularly recognized for its expertise in oncology and inflammatory disease models, offering specialized xenograft and syngeneic mouse models. In 2020, Adlego was acquired by LINK Medical Research, integrating its preclinical capabilities into a broader clinical development service offering. The company continues to operate as a specialized unit focused on bridging the gap between discovery and the clinic.